Thrombolysis in an Ischemic Stroke Patient on Dabigatran Anticoagulation: A Case Report
Authors:
- Luiz Carlos Porcello MarroneLMLuiz Carlos Porcello Marrone
- Antônio Carlos Huf MarroneAMAntônio Carlos Huf Marrone
- 1 September 2012
- journal article
- case report
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 34 (3) , 246-247
Abstract
Stroke is a leading cause of mortality and disability in many countries. Cardioembolism is one of the major causes of stroke in this population. In the south of Brazil, nearly 30% of ischemic strokes are due to cardioembolism [1].Keywords
This publication has 8 references indexed in Scilit:
- Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental strokeAnnals of Neurology, 2012
- Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patientsActa Neurochirurgica, 2011
- Fatal Intracerebral Hemorrhage Associated with Administration of Recombinant Tissue Plasminogen Activator in a Stroke Patient on Treatment with DabigatranCerebrovascular Diseases, 2011
- Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatranThrombosis and Haemostasis, 2011
- Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with DabigatranCerebrovascular Diseases, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysisBritish Journal of Clinical Pharmacology, 2006
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995